PMC:7696151 / 117004-117448 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"4107","span":{"begin":88,"end":96},"obj":"Species"},{"id":"4108","span":{"begin":349,"end":357},"obj":"Species"},{"id":"4151","span":{"begin":98,"end":101},"obj":"Chemical"},{"id":"4152","span":{"begin":203,"end":206},"obj":"Chemical"},{"id":"4153","span":{"begin":310,"end":313},"obj":"Chemical"},{"id":"4154","span":{"begin":383,"end":389},"obj":"Chemical"},{"id":"4155","span":{"begin":405,"end":408},"obj":"Chemical"},{"id":"4225","span":{"begin":70,"end":78},"obj":"Disease"},{"id":"4226","span":{"begin":79,"end":87},"obj":"Disease"},{"id":"4227","span":{"begin":259,"end":294},"obj":"Disease"}],"attributes":[{"id":"A4107","pred":"tao:has_database_id","subj":"4107","obj":"Tax:9606"},{"id":"A4108","pred":"tao:has_database_id","subj":"4108","obj":"Tax:9606"},{"id":"A4151","pred":"tao:has_database_id","subj":"4151","obj":"MESH:D006886"},{"id":"A4152","pred":"tao:has_database_id","subj":"4152","obj":"MESH:D006886"},{"id":"A4153","pred":"tao:has_database_id","subj":"4153","obj":"MESH:D006886"},{"id":"A4154","pred":"tao:has_database_id","subj":"4154","obj":"MESH:D010100"},{"id":"A4155","pred":"tao:has_database_id","subj":"4155","obj":"MESH:D006886"},{"id":"A4225","pred":"tao:has_database_id","subj":"4225","obj":"MESH:C000657245"},{"id":"A4226","pred":"tao:has_database_id","subj":"4226","obj":"MESH:D007239"},{"id":"A4227","pred":"tao:has_database_id","subj":"4227","obj":"MESH:D012128"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Mahévas, et al. (2020) [39] Observational comparativestudy181 severe COVID-19 infected patients HCQ group -\u003e 600 mg/day (n = 92)Control group -\u003e SOC (n = 89) On day 21:Overall survival was 89% in the HCQ group and 91% in the control group;survival without acute respiratory distress syndrome was 69% in the HCQ group and 74% in the control group;patients who had been weaned from oxygen was 82% in the HCQ group and 76% in the control group."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T278","span":{"begin":265,"end":285},"obj":"Phenotype"}],"attributes":[{"id":"A278","pred":"hp_id","subj":"T278","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"Mahévas, et al. (2020) [39] Observational comparativestudy181 severe COVID-19 infected patients HCQ group -\u003e 600 mg/day (n = 92)Control group -\u003e SOC (n = 89) On day 21:Overall survival was 89% in the HCQ group and 91% in the control group;survival without acute respiratory distress syndrome was 69% in the HCQ group and 74% in the control group;patients who had been weaned from oxygen was 82% in the HCQ group and 76% in the control group."}

{"project":"LitCovid-sentences","denotations":[{"id":"T778","span":{"begin":0,"end":444},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Mahévas, et al. (2020) [39] Observational comparativestudy181 severe COVID-19 infected patients HCQ group -\u003e 600 mg/day (n = 92)Control group -\u003e SOC (n = 89) On day 21:Overall survival was 89% in the HCQ group and 91% in the control group;survival without acute respiratory distress syndrome was 69% in the HCQ group and 74% in the control group;patients who had been weaned from oxygen was 82% in the HCQ group and 76% in the control group."}